Cost-effectiveness and public health impact of RTS,S/AS01 (E) malaria vaccine in Malawi, using a Markov static model

Background: The RTS,S/AS01 (E )malaria vaccine is being assessed in Malawi, Ghana and Kenya as part of a large-scale pilot implementation programme. Even if impactful, its incorporation into immunisation programmes will depend on demonstrating cost-effectiveness. We analysed the cost-effectiveness a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ndeketa, Latif, Mategula, Donnie, Terlouw, Dianne J., Bar-Zeev, Naor, Sauboin, Christophe J., Biernaux, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491149/
https://www.ncbi.nlm.nih.gov/pubmed/34632084
http://dx.doi.org/10.12688/wellcomeopenres.16224.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491149/
https://www.ncbi.nlm.nih.gov/pubmed/34632084
http://dx.doi.org/10.12688/wellcomeopenres.16224.2

Ejemplares similares